Command Palette

Search for a command to run...

Pharma

Company
Net Sales (Cr)
Revenue YoY % (Q3)
Revenue YoY % (1 Y)
Revenue CAGR % (3 Y)
EBITDA Margin % (Q3)
EBITDA Margin % (1 Y)
EBITDA Margin % (3 Y)
EPS YoY % (Q3)
EPS YoY % (1 Y)
PAT Margin % (Q3)
PAT Margin % (1 Y)
5,25,784.40 Cr8.14%8.42%10.80%27.77%30.18%24.83%-18.92%14.29%16.62%20.85%
3,26,439.00 Cr19.89%16.54%14.86%29.61%29.61%27.09%21.55%1.27%18.60%17.54%
1,52,617.00 Cr12.76%3.43%23.09%26.17%29.93%26.70%154.87%-1.05%10.40%9.37%
91,511.80 Cr7.90%11.99%140.74%22.48%18.06%13.32%50.65%392.86%5.57%1.00%
78,959.97 CrN/AN/A10.48%18.24%19.26%19.43%N/AN/A9.32%8.96%
66,720.80 Cr16.66%7.12%132.54%16.13%16.15%15.15%-12.02%-5.27%8.85%8.72%
55,539.60 Cr19.49%10.18%124.09%27.79%20.42%23.84%210.00%123.15%13.53%6.45%
46,481.00 Cr11.04%10.44%140.51%26.94%29.13%19.61%11.80%13.48%19.25%19.80%
37,492.10 Cr4.79%8.56%-51.46%38.37%35.55%27.00%35.19%57.22%26.98%24.74%
27,115.00 Cr9.41%3.66%133.11%19.15%16.76%15.01%161.66%102.15%6.02%0.12%
23,870.30 Cr9.16%-5.60%-54.22%14.07%12.71%12.39%33.59%-1.13%9.28%7.04%
21,150.80 Cr11.47%14.17%-43.93%25.55%22.43%20.41%35.42%25.62%15.67%12.88%
18,115.80 Cr10.11%7.17%-51.07%10.06%10.62%8.80%-35.19%17.02%4.36%6.51%
15,513.70 Cr11.21%13.26%3.17%11.76%10.73%4.91%1025.00%161.11%2.58%2.08%
14,448.50 Cr482.36%740.42%124.22%43.53%18.15%-141.16%189.04%98.27%23.29%-1.20%
11,975.80 Cr58.95%13.91%-55.07%20.93%36.22%42.32%-21.43%-10.85%9.63%22.11%
10,068.80 Cr37.13%40.34%-42.15%29.41%24.73%21.42%127.41%239.79%20.33%15.93%
8,097.26 Cr-0.07%5.13%-52.33%16.75%20.15%20.44%267.05%10.93%8.41%11.15%
5,617.12 Cr-64.86%-56.15%-62.18%308.91%90.50%22.57%-60.55%-59.15%160.79%44.59%
5,050.48 CrN/A8.95%-47.90%N/A7.29%4.03%N/A37.50%N/A3.16%
3,403.80 Cr53.32%32.26%-45.65%4.00%4.21%13.98%-2222.58%-367.20%-9.08%-12.83%
3,111.02 Cr3.37%2.15%9.80%16.53%22.20%25.58%-75.80%36.21%1.88%9.27%
1,983.18 Cr36.61%28.47%-44.21%26.61%21.49%15.05%188.84%81.03%16.69%12.58%
1,877.38 Cr5.76%-0.52%-89.52%14.39%15.15%13.80%30.77%19.93%5.97%6.15%
1,692.06 Cr11.81%8.87%-49.96%10.42%10.77%15.30%-90.08%-96.47%1.16%0.36%
1,333.82 Cr88.92%-26.74%N/A2.62%0.57%4.41%148.48%-492.31%1.22%-1.65%
1,207.51 Cr21.91%15.67%-54.38%9.34%15.48%8.31%96.33%219.59%4.66%9.03%
1,162.69 Cr-33.67%-22.00%-21.16%6.84%-7.46%-40.74%-207.94%29.74%-21.86%-27.49%
1,124.52 Cr69.10%3.41%-53.56%6.70%24.99%19.67%-155.56%16.60%-5.32%17.34%
969.86 CrN/A-6.59%-49.01%N/A18.08%9.11%N/A86.15%N/A9.56%
928.47 Cr-55.54%-36.45%-70.30%-0.29%-0.28%12.64%43.27%-23.78%-12.25%-13.37%
869.65 CrN/A94.86%-26.35%N/A26.55%20.59%N/A85.14%N/A12.07%
750.58 Cr29.93%25.66%-39.06%2.94%4.21%9.17%-16.67%-32.50%0.60%1.54%
717.63 CrN/A14.78%-35.51%N/A8.34%7.56%N/A-26.84%N/A3.90%
466.72 Cr4.53%2.69%-55.05%42.06%54.24%40.08%38.00%180.00%8.65%15.60%
452.59 Cr-33.54%0.73%-57.50%10.07%9.17%9.16%111.76%-27.66%0.38%0.74%
381.88 CrN/AN/AN/AN/A17.50%N/AN/AN/AN/A10.60%
226.12 Cr-66.95%-36.98%-67.41%-163.00%-26.14%5.77%-442.02%-203.01%-117.31%-22.47%

* The "N/A" values for ratios indicate that the current financial data is unavailable.

* The reported period reflects the quarter ending in March.

* The year period reflects the year ending in 2024.

* Sector metrics are based on the top 10 market cap companies; if fewer are available, metrics are adjusted accordingly.